GSK and Plasticell to manufacture haematopoietic cells from iPSC

GSK has entered a collaboration to use UK-based firm Plasticell ’s combinatorial stem cell screening technology, CombiCult, to develop haematopoietic cells from induced pluripotent stem cells (iPSC).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news